Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Boder

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biotechnology and Bioengineering|October 5, 1988
Large-scale production of monoclonal antibodies in suspension cultureM P Backer, L S Metzger, P L Slaber, et al.
Cancer Letters|January 6, 1995
Sulofenur cytotoxicity and changes in cytosolic calcium and mitochondrial membrane potential in human colon adenocarcinoma cell linesP C Phelps, P T Jain, I K Berezesky, et al.
Anticancer Research|November 1, 1993
Effect of albumin on antitumor activity of diarylsulfonylureasR M Schultz, S L Andis, J E Toth, et al.
Cancer Letters|September 10, 1996
H-ras transfection of the rat kidney cell line NRK-52E results in increased induction of c-fos, c-jun and hsp70 following sulofenur treatmentH Gu, M W Smith, P C Phelps, et al.
Cancer Research|July 15, 1990
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine)L W Hertel, G B Boder, J S Kroin, et al.
Cancer Letters|October 20, 1995
Studies on the mechanism of sulofenur and LY295501 toxicity: effect on the regulation of cytosolic calcium in relation to cytotoxicity in normal and tumorigenic rat kidney cell linesP C Phelps, C J Best, I K Berezesky, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Seminars in Oncology|August 1, 1995
Medicinal chemistry of difluoropurinesS L Andis, J R Bewley, G B Boder, et al.
Journal of Medicinal Chemistry|March 14, 1997
Sulfonimidamide analogs of oncolytic sulfonylureasJ E Toth, G B Grindey, W J Ehlhardt, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biotechnology and Bioengineering|October 5, 1988
Large-scale production of monoclonal antibodies in suspension cultureM P Backer, L S Metzger, P L Slaber, et al.
Cancer Letters|January 6, 1995
Sulofenur cytotoxicity and changes in cytosolic calcium and mitochondrial membrane potential in human colon adenocarcinoma cell linesP C Phelps, P T Jain, I K Berezesky, et al.
Anticancer Research|November 1, 1993
Effect of albumin on antitumor activity of diarylsulfonylureasR M Schultz, S L Andis, J E Toth, et al.
Cancer Letters|September 10, 1996
H-ras transfection of the rat kidney cell line NRK-52E results in increased induction of c-fos, c-jun and hsp70 following sulofenur treatmentH Gu, M W Smith, P C Phelps, et al.
Cancer Research|July 15, 1990
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine)L W Hertel, G B Boder, J S Kroin, et al.
Cancer Letters|October 20, 1995
Studies on the mechanism of sulofenur and LY295501 toxicity: effect on the regulation of cytosolic calcium in relation to cytotoxicity in normal and tumorigenic rat kidney cell linesP C Phelps, C J Best, I K Berezesky, et al.
Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.
Seminars in Oncology|August 1, 1995
Medicinal chemistry of difluoropurinesS L Andis, J R Bewley, G B Boder, et al.
Journal of Medicinal Chemistry|March 14, 1997
Sulfonimidamide analogs of oncolytic sulfonylureasJ E Toth, G B Grindey, W J Ehlhardt, et al.
Pageof 2